PPR platforms, says Nakamura, could help unlock the therapeutic potential of RNA editing for diseases ranging from age-related macular degeneration (AMD) to various neurological conditions.

Priya Basu, executive head of the Pandemic Fund, talks to Devex about the urgent need to strengthen global pandemic prevention, preparedness, and response, and the impact of the fund’s catalytic ...

In this study, it was demonstrated that a single administration of the jointly developed PPR protein (CUG-PPR1 ... 1 (hereinafter referred to as "the Disease"), resulted in long-term amelioration ...